Ensoma (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- February 12, 2021
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $70,000,000
Company Info
- Founders
- Kush M. Parmar
- Company Description
- Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.
- Market
- Gene Editing
- Location
- Boston, MA, USA
- Coinvestors
- 5AM Ventures, Alexandria Venture Investments, Cormorant Asset Management, F-Prime Capital Partners, RIT Capital, Symbiosis, Takeda Ventures, Viking Global Investors